A CEO with multiple billion-dollar cures in hand would want to make as much noise about it as possible.
They wouldn't schedule a private annual meeting limited to shareholders only, on a Sunday morning when even most shareholders won't bother listening in. 6:30 a.m. PST pretty much excludes the west coast.
They would open the meeting to the public. They'd notify every pharma who could be a potential partner, as well as every analyst, journalist, and popular blog who covers microcap biotech. And they'd have it at a usual time to maximize attendance, impact, and subsequent publicity; during a weekday shortly after market close or before market open.
Market Data 
Markets 
AI
